The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study

Review Article | By Ibrahim NE, Januzzi JL Jr.

中国心力衰竭诊断和治疗指南2018

Guideline | By 中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会中华心血管病杂志编辑委员会

In-stent neoatherosclerosis: a final common pathway of late stent failure

Review Article | By Park SJ, Kang SJ, Virmani R et al.

Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease

Original Research | By Müller J, Heck PB, Ewert P et al.

Echocardiographic Screening for Pulmonary Hypertension in Congenital Heart Disease

Review Article | By K Dimopoulos, R Condliffe, the CHAMPION Steering Committee.

Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study

Clinical Trial | By Galiè N, Beghetti M, Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators.

SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL

Original Research | By Cavender MA, Norhammar A, CVD-REAL Investigators and Study Group.

Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors

Original Research | By S Verma, S Rawat, KL Ho et al.

Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study

Clinical Trial | By Kosiborod M, Lam CSP, CVD-REAL Investigators and Study Group.

IVUS in bifurcation stenting: what have we learned?

Review Article | By Legutko J, Yamawaki M, Costa RA et al.